Sources
*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.
*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.
*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.
*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.
1 Nearly 1 in 6 of world’s population suffer from neurological disorders – UN report. UN News Center: 27 Feb. 2007. reviewed 10/30/16
2 Mental Health Action Plan. WHO: 2013, Page 8, paragraph 1. Reviewed 10/30/16
3 WHO Media Center Fact Sheet No. 307. WHO: 2013. Reviewed 10/30/16
1Baker M.G., Kale R., Menken M. The wall between neurology and psychiatry. BMJ. 2002 Jun 22; 324(7352): 1468–1469. [Internet] Accessed Jan 2017.
2McGovern Institute. Brain Disorders by the Numbers. [Internet]. Accessed Oct 2016.
3Hirsch L, et al, The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis. Neuroepidemiology 2016;46:292-300. [Internet] Accessed Jan 2017.
4Parkinson Association of the Carolinas, Statistics on Parkinson’s Disease. [Internet] Accessed Nov. 15, 2016.
5Chen S-Y, Tsai S-T, The Epidemiology of Parkinson’s Disease. Tzu Chi Medical Journal, V22, Issue 2, 2010 Jun; 73-81. [Internet] Accessed Jan 2017
1Swann A.C. Long-term treatment in bipolar disorder. Journal of Clinical Psychiatry. 2005; 66(1):7–12.
2National Institute of Mental Health. Bipolar Disorder. [Internet]. Accessed March 17, 2016.
3 “Bipolar Disorder.” Decision Resources. Table 2-2. Burlington, MA. December 2013.
4National Alliance on Mental Illness. The Impact and Cost of Mental Illness: The Case of Bipolar Disorder. [Internet]. Accessed March 17, 2016.
5 National Alliance on Mental Illness. A Primer on Depressive, Bipolar and Anxiety Illnesses: Facts for Policymakers. [Internet]. Accessed March 17, 2016.
6American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000.
7 The Depression and Bipolar Support Alliance. Mood Disorders and Different Kinds of Depression. [Internet]. Accessed March 17, 2016.
8Huxley N., Baldisseri R.J., Disability and its Treatment in Bipolar Disorder Patients. Bipolar Disorder. 2007; 9(1-2):183-96.
9Calabrese J.R., Hirschfeld R.M., Frye M.A., Reed M.L. Impact Of Depressive Symptoms Compared with Manic Symptoms in Bipolar Disorder: Results of a U.S. Community-Based Sample. Journal of Clinical Psychiatry. 2004; 65(11):1499-504.
10Parker G., McCraw S., Hadzi-Pavlovic D., Fletcher K. Costs Incurred By Those With Bipolar I, BipolarII And Unipolar Disorders. Journal of Affective Disorders. 2012; 149(1-3):46-55. (ePub).
11Leverich G.S., Altshuler L.L., Frye M.A., et al. Factors Associated With Suicide Attempts In 648 Patients With Bipolar Disorder In The Stanley Foundation Bipolar Network. Journal of Clinical Psychiatry. 2003; 64(5):506-15.
12National Alliance on Mental Illness. Bipolar Disorder. [Internet]. Accessed November 2016.
3World Health Organization. Schizophrenia. [Internet]. Accessed November 2016.
4National Institute of Mental Health. Schizophrenia. [Internet]. Accessed November 2016.
1American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Washington, D.C.: American Psychiatric Association, 2013.
2Centers for Disease Control and Prevention. Attention-Deficit / Hyperactivity Disorder (ADHD) Data and Statistics. [Internet]. Accessed September 2016.
3Targum S. and Adler L. Our Current Understanding of Adult ADHD. Innov Clin Neurosci. 2014 Nov-Dec; 11(11-12): 30–35.
4National Resource Center on ADHD. Statistical Prevalence of ADHD [Internet]. Accessed September 2016.
5American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Washington, D.C.: American Psychiatric Association, 2013.
6Centers for Disease Control and Prevention. Attention-Deficit / Hyperactivity Disorder (ADHD) Other Concerns and Conditions. [Internet]. Accessed September 2016.
7American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Washington, D.C.: American Psychiatric Association, 2013.
8Küpper T., Haavik J., Drexler H., Ramos-Quiroga J. A., Wermelskirchen D., Prutz C., Schauble B. (2012). The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents. International Archives of Occupational and Environmental Health, 85(8), 837–47.
1American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association, 2013.
2Hudson J.I., Hiripi E., Pope H. G., & Kessler R. C. (2007). The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61(3), 348–358.
3Smink F. R. E., van Hoeken D., & Hoek H. W. (2012). Epidemiology of Eating Disorders: Incidence, Prevalence and Mortality Rates. Current Psychiatry Reports, 14(4), 406–414.
4American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association, 2013.
5Mayo Clinic. Binge-Eating Disorder. [Internet]. Accessed September 2016.
6American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association, 2013
7National Eating Disorders Association: Binge Eating Disorder Infographic. [Internet]. Accessed October 2016.
8Healthline. Binge Eating Disorder Statistics. [Internet]. Accessed October 2016.
9National Institute of Mental Health: Eating Disorders. [Internet]. Accessed October 2016.
1Institute of Medicine (IOM). 2012. “Epilepsy across the spectrum: Promoting health and understanding.” Washington, DC: The National Academies Press.
2National Institutes of Health. “NINDS Epilepsy Information Page” Accessed July 2015.
3Epilepsy Foundation. “Complex Partial Seizures.” Accessed July 2015.
4Brodie M.J., Barry S.J.E., Bamagous G.A., Norrie J.D., Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012;78:1548-1554.
5Kwan P., Brodie M.J. “Early Identification of Refractory Epilepsy.” New England Journal of Medicine (2000): 342(5):314-9.
6Epilepsy Foundation. “If First Medicine Doesn’t Work”. Accessed November 2016.
1Denny 1999 J Neurolog Sci, v165, p18-23, table 3.
2Schrag 2000 Brain v123, p2297-2305.
3Parkinson Association of the Carolinas, Statistics on Parkinson’s Disease. [Internet] Accessed November 15, 2016.
4Parkinson Disease Foundation, Statistics on Parkinson’s. [Internet] Accessed Jan. 2017.
1Respiratory Diseases in the World: Realities of Today – Opportunities for Tomorrow. Forum of International Respiratory Societies: 2013. Accessed October 2016.
2About Chronic Respiratory Diseases. World Health Organization. Accessed October 2016
3National Heart, Lung and Blood Institute. What is COPD? [Internet]. Accessed November 2016.
1National Heart, Lung and Blood Institute. What is COPD? [Internet]. Accessed November 2016.
2Centers for Disease Control and Prevention: Morbidity and Mortality Weekly Report (MMWR). Employment and Activity Limitations Among Adults with Chronic Obstructive Pulmonary Disease — United States, 2013. March 27, 2015; 64(11). [Internet]. Accessed November 2016.
3Centers for Disease Control and Prevention. Chronic Obstructive Pulmonary Disease (COPD). [Internet] Accessed October 2016.
4World Health Organization. Burden of COPD. [Internet] Accessed October 2016.
*Sunovion was recently recognized as the 10th fastest-growing of the top 20 pharmaceutical companies in the U.S., based on sales data from IMS over the previous 12 months.